Free Cash Flow for West Pharmaceutical Services (WST)
Free Cash Flow for West Pharmaceutical Services (WST): headline value $458.00M · YoY +69.6%. Annual and quarterly series, chart, and tables are below.
Headline figure above is from the reporting period ending (reported ). Chart and table below cover the full reported history back to .
Currently viewingFree Cash FlowSwitch metric
Latest period
$458.00M
YoY change
+69.6%
5Y CAGR
+9.5%
Peak year (2025)
$468.90M
Latest annual
$468.90M
Free Cash Flow history chart for West Pharmaceutical Services (WST) from 1989 to 2025
Free Cash Flow history table for West Pharmaceutical Services (WST) from 1989 to 2025
| Fiscal year | Period ended | Reported | Free Cash Flow | YoY |
|---|---|---|---|---|
| 2025 | $468.90M | +69.6% | ||
| 2024 | $276.40M | -33.3% | ||
| 2023 | $414.50M | -5.7% | ||
| 2022 | $439.40M | +32.9% | ||
| 2021 | $330.60M | +10.9% | ||
| 2020 | $298.10M | +23.8% | ||
| 2019 | $240.80M | +30.9% | ||
| 2018 | $183.90M | +38.8% | ||
| 2017 | $132.50M | +169.3% | ||
| 2016 | $49.20M | -39.1% | ||
| 2015 | $80.80M | +14.1% | ||
| 2014 | $70.80M | +9.4% | ||
| 2013 | $64.70M | +16.8% | ||
| 2012 | $55.40M | +63.4% | ||
| 2011 | $33.90M | -47.4% | ||
| 2010 | $64.50M | +115.7% | ||
| 2009 | $29.90M | -829.3% | ||
| 2008 | -$4.10M | +1950.0% | ||
| 2007 | -$200,000 | -100.4% | ||
| 2006 | $53.50M | +69.8% | ||
| 2005 | $31.50M | +173.9% | ||
| 2004 | $11.50M | +36.9% | ||
| 2003 | $8.40M | -48.1% | ||
| 2002 | $16.20M | -242.1% | ||
| 2001 | -$11.40M | +31.0% | ||
| 2000 | -$8.70M | -245.0% | ||
| 1999 | $6.00M | -205.3% | ||
| 1998 | -$5.70M | -117.1% | ||
| 1997 | $33.30M | +5.0% | ||
| 1996 | $31.70M | +114.2% | ||
| 1995 | $14.80M | -34.8% | ||
| 1994 | $22.70M | +354.0% | ||
| 1993 | $5.00M | -56.9% | ||
| 1992 | $11.60M | -38.6% | ||
| 1991 | $18.90M | +575.0% | ||
| 1990 | $2.80M | -67.4% | ||
| 1989 | $8.60M | — |
Free Cash Flow values are taken from West Pharmaceutical Services's reported cash flow statements (10-Q quarterly and 10-K annual filings with the U.S. Securities and Exchange Commission). Each row shows the period end date and the date the filing was reported; YoY compares each figure to the same period one year earlier. Amounts are in USD as filed.
Analysis
West Pharmaceutical Services (WST) most recent annual free cash flow stands at $468.90M (2025) – surged 69.6% year-over-year.
West Pharmaceutical Services free cash flow has recorded the values shown across consecutive periods, with a +9.5% compound annual growth rate over 2020–2025 (5 years).
Across the available history, free cash flow reached its high of $468.90M in 2025 and its low of -$11.40M in 2001.
Within Healthcare, West Pharmaceutical Services (WST) ranks 9th among 8 peers we track. The peer median for free cash flow is $14.22B.
West Pharmaceutical Services Free Cash Flow by Year
West Pharmaceutical Services Free Cash Flow 2025: $468.90M
West Pharmaceutical Services free cash flow in 2025 was $468.90M, surged 69.6% from 2024. This figure represents the highest annual value in the available history.
West Pharmaceutical Services Free Cash Flow 2024: $276.40M
West Pharmaceutical Services free cash flow in 2024 was $276.40M, plunged 33.3% below 2023.
West Pharmaceutical Services Free Cash Flow 2023: $414.50M
West Pharmaceutical Services free cash flow in 2023 was $414.50M, declined 5.7% below 2022.
West Pharmaceutical Services Free Cash Flow 2022: $439.40M
West Pharmaceutical Services free cash flow in 2022 was $439.40M, surged 32.9% from 2021.
West Pharmaceutical Services Free Cash Flow 2021: $330.60M
West Pharmaceutical Services free cash flow in 2021 was $330.60M.
See more financial history for West Pharmaceutical Services (WST).
Sector peers — Free Cash Flow
Companies in the same sector as West Pharmaceutical Services, ranked by their latest free cash flow.
| Company | Free Cash Flow | Sector |
|---|---|---|
| Novo Nordisk A/S (NVO) | $28.99B | Healthcare |
| Johnson & Johnson (JNJ) | $19.70B | Healthcare |
| AbbVie Inc. (ABBV) | $17.82B | Healthcare |
| UnitedHealth Group Incorporated (UNH) | $16.07B | Healthcare |
| Merck & Co., Inc. (MRK) | $12.36B | Healthcare |
| AstraZeneca PLC (AZN) | $11.77B | Healthcare |
| Eli Lilly and Company (LLY) | $8.97B | Healthcare |
| Amgen Inc. (AMGN) | $8.10B | Healthcare |
Frequently asked questions
What is West Pharmaceutical Services's free cash flow?
Latest reported free cash flow for West Pharmaceutical Services (WST) is $458.00M (period ending March 31, 2026).
How has West Pharmaceutical Services free cash flow changed year-over-year?
West Pharmaceutical Services (WST) free cash flow changed +69.6% year-over-year on the latest annual filing.
What is the long-term growth rate of West Pharmaceutical Services free cash flow?
West Pharmaceutical Services (WST) free cash flow compound annual growth rate is +9.5% over the most recent 5 years available.
When did West Pharmaceutical Services free cash flow hit its highest annual value?
West Pharmaceutical Services free cash flow reached its highest annual value of $468.90M in 2025.
What was West Pharmaceutical Services free cash flow in 2024?
West Pharmaceutical Services (WST) free cash flow in 2024 was $276.40M.
What was West Pharmaceutical Services free cash flow in 2025?
West Pharmaceutical Services (WST) free cash flow in 2025 was $468.90M.
Metrics overview
Pick a metric for charts, filings and peers — each row shows the latest TTM or most-recent-quarter value.
Explore more
WST Overview
Company profile, financial tools, and key metrics
WST Revenue Counter
Earns $102.12 every second. See per minute, hour, and day.
WST Earnings Counter
Earns $17.21 per second net profit. See per minute, hour, and day.
WST Economic Scale
Exceeds Belize's GDP. Compare with world economies.
WST What If Invested
What if you had invested $1,000? See historical returns from any date.
WST How It Makes Money
Discover visual breakdown of $3.22B in revenue — where it comes from and where it goes.
WST Stock Seasonality
Best and worst months to invest. Historical monthly returns heatmap.
WST Price Target Scenarios
Model bear, base, and bull cases with EPS growth and exit P/E — pre-filled from analysts and history.
WST Daily Price Character
Steady · 44.8% historical win rate (green days). Streaks & record days.
WST Buybacks
1.65% TTM buyback yield. Shareholder yield & SBC comparison.
WST Stock Split History
4 splits on record. Dates, ratios, and cumulative multiple.
WST Dividend Profile
Yield: 0.29%. Safety: 6/8. See full history.
WST Dividend Calculator
How much dividend income would $1,000 have earned? Calculate from any date.
WST Dividend Forecast
Project future income with DRIP, growth assumptions, and optional monthly contributions.